FDG-PET/CT imaging biomarkers in head and neck squamous cell carcinoma

Vasavi Paidpally, Alin Chirindel, Stella Lam, Nishant Agrawal, Harry Quon, Rathan M. Subramaniam

Research output: Contribution to journalReview article

60 Citations (Scopus)

Abstract

This article discusses the value of 18F-fluoro-2-deoxyglucose PET/CT imaging biomarkers in head and neck squamous cell carcinoma. 18F-fluoro-2-deoxyglucose PET/CT is valuable at baseline staging, radiotherapy planning, therapy response assessment and in the follow-up of patients with head and neck squamous cell carcinoma. Maximum and peak standardized uptake value (SUVmax and SUVpeak), metabolic tumor volume and total lesion glycolysis are the common 18F-fluoro-2- deoxyglucose quantitative parameters that have been studied, along with qualitative assessments. These parameters will be evaluated with respect to their established or potential role as noninvasive biomarkers for patient risk stratification, treatment response and survival outcome.

Original languageEnglish (US)
Pages (from-to)633-647
Number of pages15
JournalImaging in Medicine
Volume4
Issue number6
DOIs
StatePublished - Dec 1 2012

Fingerprint

Deoxyglucose
Biomarkers
Glycolysis
Tumor Burden
Radiotherapy
Survival
Therapeutics
Carcinoma, squamous cell of head and neck

Keywords

  • FDG
  • head and neck squamous cell carcinoma
  • imaging biomarkers
  • PET/CT

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging
  • Radiological and Ultrasound Technology

Cite this

FDG-PET/CT imaging biomarkers in head and neck squamous cell carcinoma. / Paidpally, Vasavi; Chirindel, Alin; Lam, Stella; Agrawal, Nishant; Quon, Harry; Subramaniam, Rathan M.

In: Imaging in Medicine, Vol. 4, No. 6, 01.12.2012, p. 633-647.

Research output: Contribution to journalReview article

Paidpally, V, Chirindel, A, Lam, S, Agrawal, N, Quon, H & Subramaniam, RM 2012, 'FDG-PET/CT imaging biomarkers in head and neck squamous cell carcinoma', Imaging in Medicine, vol. 4, no. 6, pp. 633-647. https://doi.org/10.2217/iim.12.60
Paidpally, Vasavi ; Chirindel, Alin ; Lam, Stella ; Agrawal, Nishant ; Quon, Harry ; Subramaniam, Rathan M. / FDG-PET/CT imaging biomarkers in head and neck squamous cell carcinoma. In: Imaging in Medicine. 2012 ; Vol. 4, No. 6. pp. 633-647.
@article{b92ea601838f488da97c2ce9df55353b,
title = "FDG-PET/CT imaging biomarkers in head and neck squamous cell carcinoma",
abstract = "This article discusses the value of 18F-fluoro-2-deoxyglucose PET/CT imaging biomarkers in head and neck squamous cell carcinoma. 18F-fluoro-2-deoxyglucose PET/CT is valuable at baseline staging, radiotherapy planning, therapy response assessment and in the follow-up of patients with head and neck squamous cell carcinoma. Maximum and peak standardized uptake value (SUVmax and SUVpeak), metabolic tumor volume and total lesion glycolysis are the common 18F-fluoro-2- deoxyglucose quantitative parameters that have been studied, along with qualitative assessments. These parameters will be evaluated with respect to their established or potential role as noninvasive biomarkers for patient risk stratification, treatment response and survival outcome.",
keywords = "FDG, head and neck squamous cell carcinoma, imaging biomarkers, PET/CT",
author = "Vasavi Paidpally and Alin Chirindel and Stella Lam and Nishant Agrawal and Harry Quon and Subramaniam, {Rathan M.}",
year = "2012",
month = "12",
day = "1",
doi = "10.2217/iim.12.60",
language = "English (US)",
volume = "4",
pages = "633--647",
journal = "Imaging in Medicine",
issn = "1755-5191",
publisher = "Future Medicine Ltd.",
number = "6",

}

TY - JOUR

T1 - FDG-PET/CT imaging biomarkers in head and neck squamous cell carcinoma

AU - Paidpally, Vasavi

AU - Chirindel, Alin

AU - Lam, Stella

AU - Agrawal, Nishant

AU - Quon, Harry

AU - Subramaniam, Rathan M.

PY - 2012/12/1

Y1 - 2012/12/1

N2 - This article discusses the value of 18F-fluoro-2-deoxyglucose PET/CT imaging biomarkers in head and neck squamous cell carcinoma. 18F-fluoro-2-deoxyglucose PET/CT is valuable at baseline staging, radiotherapy planning, therapy response assessment and in the follow-up of patients with head and neck squamous cell carcinoma. Maximum and peak standardized uptake value (SUVmax and SUVpeak), metabolic tumor volume and total lesion glycolysis are the common 18F-fluoro-2- deoxyglucose quantitative parameters that have been studied, along with qualitative assessments. These parameters will be evaluated with respect to their established or potential role as noninvasive biomarkers for patient risk stratification, treatment response and survival outcome.

AB - This article discusses the value of 18F-fluoro-2-deoxyglucose PET/CT imaging biomarkers in head and neck squamous cell carcinoma. 18F-fluoro-2-deoxyglucose PET/CT is valuable at baseline staging, radiotherapy planning, therapy response assessment and in the follow-up of patients with head and neck squamous cell carcinoma. Maximum and peak standardized uptake value (SUVmax and SUVpeak), metabolic tumor volume and total lesion glycolysis are the common 18F-fluoro-2- deoxyglucose quantitative parameters that have been studied, along with qualitative assessments. These parameters will be evaluated with respect to their established or potential role as noninvasive biomarkers for patient risk stratification, treatment response and survival outcome.

KW - FDG

KW - head and neck squamous cell carcinoma

KW - imaging biomarkers

KW - PET/CT

UR - http://www.scopus.com/inward/record.url?scp=84871215580&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84871215580&partnerID=8YFLogxK

U2 - 10.2217/iim.12.60

DO - 10.2217/iim.12.60

M3 - Review article

VL - 4

SP - 633

EP - 647

JO - Imaging in Medicine

JF - Imaging in Medicine

SN - 1755-5191

IS - 6

ER -